Northwest Biotherapeutics (NWBO) Picks Up Momentum: A Good Buy?

In recent times, Northwest Biotherapeutics, Inc (OTC: NWBO) stock has emerged as one of the stocks that attracted considerable attention from investors and over the past three weeks, the stock has gained as big as 20%.

In this sort of situation, it could be the right move to have a closer look at the cancer medicine development company and its business. Last month Northwest released its financial results for the third quarter and suffered a loss of as huge as $194 million.

The company further pointed out that the losses worked out to 26 cents a share, but after adjustments, it came down to 7 cents a share. On the other hand, the revenues for the quarter came in at $216,000. Over the course of the past year or so, the stock has recorded remarkable gains. The stock closed at $1.61 a share this past Friday but back in January 2020, it was trading at only 21 cents per share.